I have some question about multiple enrollments and multiple screenings.
In 2014, PhUSE WG suggested to update the structure of DM to "One records per SUBJID". However, the FDA and CDISC did not adopt this recommendation and insist that the structure of DM should be maintained as "One records per USUBJID".
So, I want to know the reason why the DM data set must satisfy "One records per USUBJID". How will this help the review process?
Per my understanding, it's due to a fact that all analysis and reviews are performed by a complete subject experience (USUBJID), not by subject enrolment in the study(ies) (SUBJID).
Pinnacle 21 uses cookies to make our site easier for you to use. By continuing to use this website, you agree to our use of cookies. For more info visit our Privacy Policy.
Hi,
I have some question about multiple enrollments and multiple screenings.
In 2014, PhUSE WG suggested to update the structure of DM to "One records per SUBJID". However, the FDA and CDISC did not adopt this recommendation and insist that the structure of DM should be maintained as "One records per USUBJID".
So, I want to know the reason why the DM data set must satisfy "One records per USUBJID". How will this help the review process?
Kind Regards,
Marnie